Glioma clinical trials in Georgia
6 studies for Glioma are looking for participants at sites in Georgia.
Cities in Georgia
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Piedmont Oncology Research, Atlanta
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07326566ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Emory University/Children's Healthcare of Atlanta, Atlanta
RecruitingPhase 2
12 Months – 39 Years · All sexes · Updated Oct 23, 2026 · NCT06838676Tumor Treating Fields for the Treatment of Brainstem Gliomas
- Emory Proton Therapy Center, Atlanta
- Emory University/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Recruiting
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT05310448SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Emory University, Atlanta
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT05303519A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Healthcare of Atlanta - Egleston Hospital, Atlanta
RecruitingPhase 1/2
Up to age 25 · All sexes · Updated Sep 25, 2026 · NCT04094610Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
- Arthur M Blank Hospital, Atlanta
- Children's Healthcare of Atlanta: Scottish Rite, Atlanta
RecruitingPhase 1
Ages 2 to 25 · All sexes · Updated Aug 3, 2026 · NCT06624371From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.